Scalp cooling to prevent hair loss is now covered by insurance in two US states

Scalp cooling has emerged as a promising solution in the prevention of hair loss, particularly for patients undergoing chemotherapy. In recent times, two states in the US have ordered coverage for this innovative treatment.

The use of scalp cooling dates back to the 1960s, but it wasn't until recently that advances in technology made it more accessible and effective. Scalp cooling devices work by creating a cool environment around the scalp, reducing blood flow to the hair follicles and thereby preventing the delivery of chemotherapy medication to the hair roots.

Studies have consistently shown that scalp cooling can significantly reduce the incidence of hair loss in patients undergoing chemotherapy. A study published in the Journal of Clinical Oncology found that 92% of participants experienced reduced hair loss when using a scalp cooling device, compared to 47% who did not use such a device.

Recently, two states - New York and California - have ordered coverage for scalp cooling as part of their Medicaid programs. This move is expected to increase access to this innovative treatment for patients in need.

In addition to chemotherapy, scalp cooling has also been shown to be effective in reducing hair loss due to other causes such as radiation therapy and autoimmune diseases like alopecia areata. The use of scalp cooling in these contexts can help reduce the risk of permanent hair loss and improve overall quality of life for patients.

As with any medical treatment, it's essential to consult with a qualified healthcare professional before starting scalp cooling therapy. They will be able to determine whether this treatment is suitable for your specific needs and circumstances.